Addex Therapeutics Ltd
SIX:ADXN
Addex Therapeutics Ltd
SIX:ADXN
Price:
0.071 CHF
-3.79%
Market Closed
Updated:
May 15, 2024
Addex Therapeutics Ltd
Operating Expenses
|
Addex Therapeutics Ltd
Operating Expenses Peer Comparison
Comparables:
ADCT
ACIU
CRSP
BSLN
IDIA
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Addex Therapeutics Ltd
SIX:ADXN
|
Operating Expenses
-CHf11.9m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Operating Expenses
-$233m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
Operating Expenses
-CHf68.4m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Operating Expenses
-$593.7m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Operating Expenses
-CHf111.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-4%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Operating Expenses
-CHf893.8m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
See Also
What is Addex Therapeutics Ltd's Operating Expenses?
Operating Expenses
-11.9m
CHF
-11.9m
CHF
Based on the financial report for Dec 31, 2023, Addex Therapeutics Ltd's Operating Expenses amounts to -11.9m CHF.
What is Addex Therapeutics Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-8%
-8%
Over the last year, the Operating Expenses growth was 46%. The average annual Operating Expenses growth rates for Addex Therapeutics Ltd have been 10% over the past three years , -8% over the past five years .
You don't have any saved screeners yet
